HOMEVULNERABILITIESCVE-2020-14525
LOW

CVE-2020-14525

CWE-83Published: September 18, 2020· Updated: Jun 17, 2026

3.5
CVSS v3.1

Official Description

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input

before it is placed in output used as a webpage that is served to other

users.

NVD Source

Technical Analysis

CVE-2020-14525 requires adjacent network access, limiting remote exploitation but still posing risk in shared or local network environments.

Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorAdjacent
Attack ComplexityLow
Privileges Req.Low
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityLow
IntegrityNone
AvailabilityNone
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Affected Vendors & Products

philips1 product(s)
clinical collaboration platform
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (3)

Quick Facts

CVE IDCVE-2020-14525
CVSS Score3.5 / 10
SeverityLOW
WeaknessCWE-83
CISA KEVNo
Affected1 vendor(s)
PublishedSep 18, 2020

Related CVEs (CWE-83)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2020-14525 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.